FANTIN, Martina
 Distribuzione geografica
Continente #
NA - Nord America 974
EU - Europa 232
AS - Asia 196
SA - Sud America 1
Totale 1.403
Nazione #
US - Stati Uniti d'America 970
CN - Cina 105
UA - Ucraina 67
SG - Singapore 59
DE - Germania 46
GB - Regno Unito 36
IT - Italia 35
TR - Turchia 27
FI - Finlandia 20
SE - Svezia 17
FR - Francia 5
CA - Canada 4
BE - Belgio 3
CL - Cile 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
NL - Olanda 1
Totale 1.403
Città #
Fairfield 117
Woodbridge 116
Chandler 81
Ann Arbor 79
Jacksonville 76
Houston 71
Ashburn 54
Santa Clara 54
Singapore 52
Seattle 45
Wilmington 42
Cambridge 39
Beijing 24
Izmir 21
Nanjing 21
Milan 16
Princeton 16
Bremen 14
Shanghai 14
Boardman 11
San Diego 11
Falls Church 10
Jiaxing 7
New York 7
Auburn Hills 6
Helsinki 6
Los Angeles 6
Hebei 5
Ferrara 4
Jinan 4
San Mateo 4
Shenyang 4
Tianjin 4
Brussels 3
Dearborn 3
London 3
Ningbo 3
Norwalk 3
Ottawa 3
Changsha 2
Des Moines 2
Falkenstein 2
Fuzhou 2
Mountain View 2
Nanchang 2
Redwood City 2
Taizhou 2
Verona 2
Amritsar 1
Brno 1
Changchun 1
Chicago 1
Clearwater 1
Clifton 1
Coyhaique 1
Hangzhou 1
Jakarta 1
Kista 1
La Canada Flintridge 1
New Bedfont 1
Philadelphia 1
Piscataway 1
San Francisco 1
Springfield 1
Tappahannock 1
Tokyo 1
Toronto 1
Walnut 1
Washington 1
Zhengzhou 1
Totale 1.099
Nome #
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic G i/o protein linked pathways 127
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid 123
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 121
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 117
null 113
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism 113
Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease 111
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 108
null 87
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 84
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 71
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 70
Differential regulation of striato-nigral and striato-pallidal pathways by striatal NR2A and NR2B subunit containing receptors 61
NR2A and NR2B Subunit Selective NMDA antagonists improve motor performance and reduce pallidal GABA release in 6-OHDA hemilesioned rats 61
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 29
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways 17
Totale 1.413
Categoria #
all - tutte 6.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 0 0 0 0 0 25 27 20 24 26 8
2020/2021197 14 17 9 22 20 16 1 32 0 22 23 21
2021/2022147 5 21 12 7 3 10 10 4 5 9 15 46
2022/2023190 18 5 16 18 41 24 16 16 27 0 5 4
2023/202459 9 6 4 3 1 11 2 4 2 1 0 16
2024/2025140 10 8 24 8 45 45 0 0 0 0 0 0
Totale 1.413